AI in drug discovery is accelerating the process of finding new treatments for diseases. Researchers are using AI to analyze vast amounts of data and identify potential drug targets. This approach has the potential to revolutionize the field of drug discovery.
Key points
AI-powered drug discovery: AI is being used to analyze large datasets and identify potential drug targets. This approach has the potential to accelerate the drug discovery process and lead to the development of new treatments for diseases.
Data analysis: AI is being used to analyze vast amounts of data, including genomic data, to identify potential drug targets. This approach has the potential to lead to the development of new treatments for diseases.
Collaboration: Researchers are working together to develop new AI-powered approaches to drug discovery. This collaboration has the potential to lead to breakthroughs in the field.
Sources

Tech News - Weather Modification
Rainmaker has raised $100M to become the world's best lab for weather modification and atmospheric science. The company is aggressively hiring and scaling its research organization to create a new generation of weather modification technologies.
Key points
Weather modification: Rainmaker is working on developing new weather modification technologies. The company is using a combination of AI and machine learning to improve the accuracy of its weather forecasts.
Research organization: Rainmaker is aggressively hiring and scaling its research organization to create a new generation of weather modification technologies.
Funding: Rainmaker has raised $100M to support its research and development efforts.
Sources

Tech News - CD Baby
CD Baby founder, Derek Sivers, worked on the platform for 12-18 hours per day, 7 days a week, for four years before it really took off. Sivers has been creating and posting content online for free since 1994.
Key points
CD Baby: CD Baby is a music distribution platform that allows artists to upload and sell their music online.
Derek Sivers: Sivers is the founder of CD Baby and has been creating and posting content online for free since 1994.
Hard work: Sivers worked on CD Baby for 12-18 hours per day, 7 days a week, for four years before it really took off.
Sources

Tech News - Tokenization
$BONER already drives over 2% of $HIMS volume. EllioTrades says this is the beginning of a tokenization supercycle, as companies start to realize what onchain markets can do for their stocks.
Key points
Tokenization: Tokenization is the process of converting assets into digital tokens that can be traded on blockchain markets.
$BONER: $BONER is a token that has already driven over 2% of $HIMS volume.
Tokenization supercycle: EllioTrades believes that tokenization is the beginning of a new supercycle, as companies start to realize the potential of onchain markets.
Sources

Tech News - Drug Targets
The evolving landscape of drug targets has expanded to include ~700 targets mapped here. Advances in areas such as genomics and the diversification of therapeutic modalities have led to this expansion.
Key points
Drug targets: Drug targets are the specific molecules or proteins that a drug is designed to interact with.
Evolving landscape: The landscape of drug targets is constantly evolving, with new targets being discovered and old ones being refined.
Genomics: Advances in genomics have led to a better understanding of the genetic basis of disease, which has in turn led to the discovery of new drug targets.
Sources
Tech News - Replit
Replit has changed the life of many developers, including the author of this tweet. The company has provided a platform for developers to build and deploy applications, and has also provided a community for developers to learn and grow.
Key points
Replit: Replit is a platform that allows developers to build and deploy applications.
Community: Replit has also provided a community for developers to learn and grow.
Impact: Replit has had a significant impact on the lives of many developers.
Sources

Tech News - Ozempic
Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy, and Zepbound, claiming the drugs led to a rare type of vision loss. ABC News' Elizabeth Schulze reports.
Key points
Ozempic: Ozempic is a popular GLP-1 drug that has been linked to a rare type of vision loss.
Lawsuits: Dozens of lawsuits have been filed against the companies behind Ozempic, Wegovy, and Zepbound.
Vision loss: The lawsuits claim that the drugs led to a rare type of vision loss.
Sources

Tech News - IBM Bob
It is one thing to build an AI agent. It is another to understand the impact it is having across your team and delivery process. @_malcolmadams shared a great perspective on IBM Bob and the analytics behind it.
Key points
IBM Bob: IBM Bob is an AI agent that has been designed to help teams and delivery processes.
Analytics: The analytics behind IBM Bob have been shared by @_malcolmadams.
Impact: The impact of IBM Bob on teams and delivery processes is significant.
Sources

Tech News - CD Baby Distribution
We saw how popular and wide spread this distribution method became and believe it's the first of many to come. We already had some infrastructure and determined it could be a valued service. Anything not filled will be reverted, we will keep you updated as the cutoff approaches.
Key points
CD Baby distribution: CD Baby has a distribution method that has become popular and widespread.
Infrastructure: CD Baby already had some infrastructure in place to support the distribution method.
Cutoff: The cutoff for the distribution method is approaching, and CD Baby will keep users updated.
Sources

Tech News - Podcast with @bubbleboi
Dropping a podcast with the one and only @bubbleboi Mr. Bubble is world class at explaining very technical concepts in layman terms. In this episode I wanted to chat through the 0 to 1 of the chips, racks, packaging, the memory hierarchy, scaling up and scaling out.
Key points
Podcast: The podcast is with @bubbleboi, who is world class at explaining technical concepts in layman terms.
Technical concepts: The podcast covers technical concepts such as chips, racks, packaging, and the memory hierarchy.
Scaling: The podcast also covers scaling up and scaling out.
Sources
